A49.9
Conditions
Interventions
Group 1: Detection of a chronic bacterial infectious disease of airways, mucosa or skin by non-invasive measurement of air samples with ion mobility spectrometry (IMS). Differentiation of antibiotic r
Sponsors
Graupner medical solutions GmbH
Eligibility
Sex/Gender
All
Age
18 Years to 90 Years
Inclusion criteria
Inclusion criteria: lung disease infection of the upper airways local skin or airway infection by putative MRSA or other resistent germ virus infection clinically present
Exclusion criteria
Exclusion criteria: Severe impairment of lung function with inability to perform a slow expiratory VK maneuver of more than 6 sec. Unclear illnesses and medication intake Lack of cooperation or legal capacity of the patient or suspicion that the necessary data of the patient cannot be collected Lack of consent
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary objective of this study is to demonstrate that reproducibly identical patterns of markers in the IMS spectrum from exhaled air and biological samples are detectable that provide reliable evidence of pulmonary disease. | — |
Countries
Germany
Contacts
Public ContactMario Kuhnert
Asklepios Klinik Birkenwerder
Outcome results
None listed